Benzinga's Top Upgrades, Downgrades For October 1, 2019

Upgrades

  • KeyBanc changed the rating for Analog Devices Inc ADI from Sector Weight to Overweight. In the third quarter, Analog Devices showed an EPS of $1.26, compared to $1.53 from the year-ago quarter. Analog Devices's market cap stands at $40.9 billion. The stock has a 52-week-high of $124.78 and a 52-week-low of $76.62. Analog Devices's stock last closed at $111.73 per share.
  • Daiwa Capital upgraded the stock for China Mobile Ltd CHL from Outperform to Buy. The current market cap for China Mobile is at $169.3 billion. The stock has a 52-week-high of $55.84 and a 52-week-low of $39.77. China Mobile's stock last closed at $41.42 per share.
  • For Envestnet Inc ENV, DA Davidson upgraded the stock from Neutral to Buy. Envestnet earned $0.46 in the second quarter, compared to $0.41 in the year-ago quarter. Envestnet's market cap stands at $3.0 billion. The stock has a 52-week-high of $73.94 and a 52-week-low of $46.57. Envestnet's stock last closed at $56.72 per share.
  • Bank of America upgraded the stock for National Vision Holdings Inc EYE from Neutral to Buy. National Vision Holdings earned $0.20 in the second quarter, compared to $0.21 in the year-ago quarter. The current market cap for National Vision Holdings is at $1.9 billion. The stock has a 52-week-high of $45.88 and a 52-week-low of $23.48. National Vision Holdings's stock last closed at $24.07 per share.
  • KeyBanc upgraded the stock for Microchip Technology Inc MCHP from Sector Weight to Overweight. In the first quarter, Microchip Technology showed an EPS of $1.41, compared to $1.61 from the year-ago quarter. Microchip Technology's market cap stands at $21.5 billion. The stock has a 52-week-high of $101.35 and a 52-week-low of $60.70. Microchip Technology's stock last closed at $92.91 per share.
  • For NXP Semiconductors NV NXPI, KeyBanc upgraded the stock from Sector Weight to Overweight. For the second quarter, NXP Semiconductors had an EPS of $1.91, compared to year-ago quarter EPS of $1.50. The current market cap for NXP Semiconductors is at $28.9 billion. The stock has a 52-week-high of $112.06 and a 52-week-low of $67.62. NXP Semiconductors's stock last closed at $109.12 per share.
  • Bank of America changed the rating for Philip Morris International Inc PM from Neutral to Buy. Philip Morris Intl earned $1.46 in the second quarter, compared to $1.41 in the year-ago quarter. Philip Morris Intl's market cap stands at $111.3 billion. The stock has a 52-week-high of $92.74 and a 52-week-low of $64.67. Philip Morris Intl's stock last closed at $75.92 per share.
  • Bank of America upgraded the stock for The Scotts Miracle Gro Co SMG from Underperform to Neutral. In the third quarter, The Scotts Miracle Gro showed an EPS of $3.11, compared to $2.67 from the year-ago quarter. The current market cap for The Scotts Miracle Gro is at $5.6 billion. The stock has a 52-week-high of $114.63 and a 52-week-low of $57.96. The Scotts Miracle Gro's stock last closed at $101.79 per share.
  • Evercore ISI Group upgraded the stock for Spotify Technology SA SPOT from Underperform to In-Line. Spotify Technology earned ($0.47) in the second quarter, compared to ($2.57) in the year-ago quarter. The current market cap for Spotify Technology is at $20.9 billion. The stock has a 52-week-high of $184.95 and a 52-week-low of $103.29. Spotify Technology's stock last closed at $114.07 per share.
  • Barclays upgraded the stock for Tradeweb Markets Inc TW from Equal-Weight to Overweight. For the second quarter, Tradeweb Markets had an EPS of $0.25, compared to year-ago quarter EPS of $0.23. Tradeweb Markets's market cap stands at $8.7 billion. The stock has a 52-week-high of $50.48 and a 52-week-low of $33.68. Tradeweb Markets's stock last closed at $36.98 per share.
  • Wells Fargo upgraded the stock for VMware Inc VMW from Market Perform to Outperform. For the second quarter, VMware had an EPS of $1.60, compared to year-ago quarter EPS of $1.54. The current market cap for VMware is at $59.7 billion. The stock has a 52-week-high of $206.80 and a 52-week-low of $128.69. VMware's stock last closed at $150.10 per share.

 

Downgrades

  • For Celanese Corp CE, Goldman Sachs downgraded the stock from Buy to Neutral. In the second quarter, Celanese showed an EPS of $2.38, compared to $2.90 from the year-ago quarter. Celanese's market cap stands at $15.0 billion. The stock has a 52-week-high of $127.15 and a 52-week-low of $82.91. Celanese's stock last closed at $122.29 per share.
  • Stephens & Co. changed the rating for Canadian National Railway Co CNI from Overweight to Equal-Weight. Canadian National Railway earned $1.29 in the second quarter, compared to $1.17 in the year-ago quarter. The total market value of Canadian National Railway's outstanding shares is at $64.1 billion. The stock has a 52-week-high of $96.49 and a 52-week-low of $70.36. Canadian National Railway's stock last closed at $89.87 per share.
  • Guggenheim Securities changed the rating for Five Prime Therapeutics Inc FPRX from Buy to Neutral. For the second quarter, Five Prime Therapeutics had an EPS of ($0.99), compared to year-ago quarter EPS of ($0.99). The current market cap for Five Prime Therapeutics is at $180.9 million. The stock has a 52-week-high of $14.48 and a 52-week-low of $3.86. Five Prime Therapeutics's stock last closed at $3.88 per share.
  • RBC Capital downgraded the stock for nVent Electric PLC NVT from Outperform to Sector Perform. nVent Electric earned $0.44 in the second quarter. nVent Electric's market cap stands at $3.6 billion. The stock has a 52-week-high of $28.49 and a 52-week-low of $19.28. nVent Electric's stock last closed at $22.03 per share.
  • Evercore ISI Group changed the rating for Public Storage PSA from In-Line to Underperform. Public Storage earned $2.64 in the second quarter, compared to $2.57 in the year-ago quarter. The total market value of Public Storage's outstanding shares is at $43.2 billion. The stock has a 52-week-high of $266.76 and a 52-week-low of $193.89. Public Storage's stock last closed at $245.25 per share.
  • Cowen & Co. downgraded the stock for US Silica Holdings Inc SLCA from Outperform to Market Perform. US Silica Holdings earned $0.14 in the second quarter, compared to $0.64 in the year-ago quarter. US Silica Holdings's market cap stands at $799.8 million. The stock has a 52-week-high of $20.82 and a 52-week-low of $8.72. US Silica Holdings's stock last closed at $9.55 per share.
  • For SL Green Realty Corp SLG, Stifel Nicolaus downgraded the stock from Buy to Hold. SL Green Realty earned $1.82 in the second quarter, compared to $1.69 in the year-ago quarter. The current market cap for SL Green Realty is at $6.6 billion. The stock has a 52-week-high of $98.04 and a 52-week-low of $75.45. SL Green Realty's stock last closed at $81.73 per share.
  • Stephens & Co. downgraded the stock for Ubisoft Entertainment UBSFY from Overweight to Equal-Weight. The current market cap for Ubisoft is at $8.3 billion. The stock has a 52-week-high of $24.29 and a 52-week-low of $14.04. Ubisoft's stock last closed at $14.32 per share.
  • Barclays downgraded the stock for Welltower Inc WELL from Overweight to Equal-Weight. For the second quarter, Welltower had an EPS of $1.05, compared to year-ago quarter EPS of $1.00. The total market value of Welltower's outstanding shares is at $36.1 billion. The stock has a 52-week-high of $92.50 and a 52-week-low of $60.93. Welltower's stock last closed at $90.66 per share.
  • KeyBanc changed the rating for Xilinx Inc XLNX from Overweight to Sector Weight. For the first quarter, Xilinx had an EPS of $0.97, compared to year-ago quarter EPS of $0.74. Xilinx's market cap stands at $24.2 billion. The stock has a 52-week-high of $141.60 and a 52-week-low of $68.76. Xilinx's stock last closed at $95.90 per share.

 

Initiations

  • With a rating of Outperform, RBC Capital initiated coverage on ACADIA Pharmaceuticals Inc ACAD. The price target is set at $60.00 for ACADIA Pharmaceuticals. ACADIA Pharmaceuticals earned ($0.38) in the second quarter, compared to ($0.51) in the year-ago quarter. ACADIA Pharmaceuticals's market cap stands at $5.5 billion. The stock has a 52-week-high of $44.85 and a 52-week-low of $14.01. ACADIA Pharmaceuticals's stock last closed at $35.99 per share.
  • Berenberg initiated coverage on Agree Realty Corp ADC with a Buy rating. The price target for Agree Realty is set at $82.00. For the second quarter, Agree Realty had an EPS of $0.74, compared to year-ago quarter EPS of $0.70. The total market value of Agree Realty's outstanding shares is at $3.0 billion. The stock has a 52-week-high of $76.23 and a 52-week-low of $50.72. Agree Realty's stock last closed at $73.12 per share.
  • With a rating of Hold, Stifel initiated coverage on bluebird bio Inc BLUE. The price target is set at $109.00 for bluebird bio. In the second quarter, bluebird bio showed an EPS of ($3.55), compared to ($2.91) from the year-ago quarter. bluebird bio's market cap stands at $5.8 billion. The stock has a 52-week-high of $163.43 and a 52-week-low of $87.49. bluebird bio's stock last closed at $91.82 per share.
  • With a rating of Outperform, Wells Fargo initiated coverage on Blackstone Group Inc BX. The price target is set at $60.00 for Blackstone Group. For the second quarter, Blackstone Group had an EPS of $0.45, compared to year-ago quarter EPS of $0.90. The total market value of Blackstone Group's outstanding shares is at $63.1 billion. The stock has a 52-week-high of $55.17 and a 52-week-low of $26.88. Blackstone Group's stock last closed at $48.86 per share.
  • Stifel initiated coverage on Fate Therapeutics Inc FATE with a Buy rating. The price target for Fate Therapeutics is set at $27.00. For the second quarter, Fate Therapeutics had an EPS of ($0.36), compared to year-ago quarter EPS of ($0.37). The total market value of Fate Therapeutics's outstanding shares is at $1.0 billion. The stock has a 52-week-high of $22.82 and a 52-week-low of $11.00. Fate Therapeutics's stock last closed at $15.53 per share.
  • Stifel initiated coverage on Iovance Biotherapeutics Inc IOVA with a Buy rating. The price target for Iovance Biotherapeutics is set at $27.00. In the second quarter, Iovance Biotherapeutics showed an EPS of ($0.38), compared to ($0.34) from the year-ago quarter. Iovance Biotherapeutics's market cap stands at $2.5 billion. The stock has a 52-week-high of $26.59 and a 52-week-low of $7.26. Iovance Biotherapeutics's stock last closed at $18.20 per share.
  • Raymond James initiated coverage on WEX Inc WEX with a Market Perform rating. WEX earned $2.28 in the second quarter, compared to $2.09 in the year-ago quarter. The current market cap for WEX is at $8.6 billion. The stock has a 52-week-high of $221.66 and a 52-week-low of $131.35. WEX's stock last closed at $202.02 per share.

Posted In: Information TechnologyInitiationsSemiconductorstop upgradesUpgradesDowngradesInitiationIntraday UpdateAnalyst Ratings

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.